Versant Venture Management as of June 30, 2024
Portfolio Holdings for Versant Venture Management
Versant Venture Management holds 8 positions in its portfolio as reported in the June 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| CRISPR Therapeutics Common Shares (CRSP) | 34.8 | $27M | 499k | 54.01 | |
| Contineum Therapeutics Common Stock (CTNM) | 20.9 | $16M | 918k | 17.61 | |
| Skye Bioscience Common Stock (SKYE) | 20.8 | $16M | 2.0M | 8.01 | |
| Repare Therapeutics Common Stock (RPTX) | 11.3 | $8.7M | 2.6M | 3.30 | |
| Adverum Biotechnologies Common Stock | 4.5 | $3.5M | 507k | 6.86 | |
| Passage Bio Common Stock (PASG) | 4.1 | $3.2M | 4.0M | 0.79 | |
| Gritstone Oncology Common Stock (GRTS) | 2.8 | $2.2M | 3.6M | 0.62 | |
| Aligos Therapeutics Common Stock (ALGS) | 0.7 | $510k | 1.5M | 0.35 |
